ATTOGEN BIOMEDICAL SUZHOU INC LTD has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are MACFARLANE BURNET INSTITUTE FOR MEDICAL RES AND PUBLIC HEALTH LIMITED, UNI DEGLI STUDI DI VERONA and HILDEBRAND WILLIAM H.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chang Xiaojia | 12 |
#2 | Shi Lijun | 9 |
#3 | Shi Chenglong | 8 |
#4 | Han Fengli | 6 |
#5 | Zhang Jiecheng | 5 |
#6 | Liu Yan | 3 |
#7 | Huang Yan | 3 |
#8 | Liu Fei | 1 |
#9 | Xue Weimin | 1 |
#10 | Xu Hong | 1 |
Publication | Filing date | Title |
---|---|---|
CN109425527A | A kind of cell dyeing method | |
CN109021097A | A kind of monoclonal antibody and its application identifying HPV18 and/or HPV45 | |
CN107868127A | A kind of monoclonal antibody for being used to detect Oncoprotein Expression in histopathologic slide | |
EP3241848A1 | Construction method for recombinant vaccine having anti-cervical cancer cell activity and application thereof | |
US2017315124A1 | Cervical cancer-related HPV E7 protein monoclonal antibody and use thereof | |
WO2014127741A1 | Antigen for detecting anti-human papilloma virus antibodies, test kit and applications thereof | |
CN103940993A | Antigen and kit for detecting anti-human-papillomavirus antibody and application of antigen |